Monthly Archives: March 2016

HNA Infrastructure (0357-hk, $8.99 HK). The Torrid Growth Rate Continues.

HNA Infrastructure reported the fiscal 2015 year end results. http://www.mlairport.com/autoportal/admin/upload/ReadAttach?uid=8a8181adss61c79017s1536976969ass7f71 For 2016, a 20% revenue increase produced a 31% increase in net after tax profits along with a 28.7% increase in EBITDA. EBITDA touched $99 million, which represents an EBITDA

Posted in Open Blog

Novo Nordisk (NVO-NYSE, $56.75). Victoza use Reduces Risk of Heart Attacks & Strokes

Those taking Victoza reported a statistically significant reduction in heart attack and stroke occurrence, in the largest study of its kind to date. http://www.investors.com/news/technology/novo-nordisk-diabetes-drug-cuts-deaths-from-heart-disease/?ven=YahooCP&src=AURLLED&ven=yahoo The test seems to clearly demonstrate superiority for Victoza over competing products produced by Merck and

Posted in Open Blog

MasterCard (MA-NYSE, $89.12) Preparing to Buy Vocalink?

http://www.ft.com/cms/s/0/cc15ccdc-e147-11e5-9217-6ae3733a2cd1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev#axzz41rdDb6eG In contrast with the many smaller acquisitions made by MasterCard in the past 36 months, this purchase, should it come to pass, looks to be nicely accretive to revenue and earnings, from the get-go.

Posted in Open Blog